x

Coronavirus

India Drug Maker, Russia Agree on Coronavirus Doses

September 16, 2020

NEW DELHI — An Indian pharmaceutical company and Russia’s sovereign wealth fund have agreed to distribute 100 million doses of the Russia’s experimental Sputnik V vaccine in India.

The Russian Direct Investment Fund (RDIF) says it had paired with Indian company Dr. Reddy’s Laboratories Ltd. The pharmaceutical company will be conducting phase three trials in India to meet the country’s regulatory requirements.

Press secretary Arseniy Palagin confirmed the 100 million doses of the experimental vaccine were meant for “population wide use” as long as they met regulatory requirements and clinical trials were successful.

Palagin confirmed RDIF was in talks with several Indian companies for manufacturing the vaccine.

Indian officials said last week that Russia had asked for assistance for the vaccine to be manufactured by Indian companies and the government was facilitating this.

Dr. V.K. Paul, who heads a government task force on vaccines, has called a partnership with Russia a “win-win for India and the world.”

RELATED

BEIJING (AP) — Genetic material collected at a Chinese market near where the first human cases of COVID-19 were identified show raccoon dog DNA comingled with the virus, adding evidence to the theory that the virus originated from animals, not from a lab, international experts say.

Top Stories

Columnists

A pregnant woman was driving in the HOV lane near Dallas.

General News

FALMOUTH, MA – The police in Falmouth have identified the victim in an accident involving a car plunging into the ocean on February 20, NBC10 Boston reported.

General News

NEW YORK – Meropi Kyriacou, the new Principal of The Cathedral School in Manhattan, was honored as The National Herald’s Educator of the Year.

Video

Enter your email address to subscribe

Provide your email address to subscribe. For e.g. [email protected]

You may unsubscribe at any time using the link in our newsletter.